These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6480767)

  • 1. Determination of the beta-adrenoceptor blocking drug bupranolol in plasma and tissues of the rat by high-performance liquid chromatography with ultraviolet detection.
    Winkler H; Lemmer B
    J Chromatogr; 1984 Jul; 309(1):193-7. PubMed ID: 6480767
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of the beta-adrenoceptor blocking drug sotalol in plasma and tissues of the rat by high-performance liquid chromatography with ultraviolet detection.
    Lemmer B; Ohm T; Winkler H
    J Chromatogr; 1984 Jul; 309(1):187-92. PubMed ID: 6480766
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of carboxybupranolol, the major metabolite of bupranolol, in human plasma by high-performance liquid chromatography.
    Walmsley LM; Brodie RR; Chasseaud LF
    J Chromatogr; 1984 Nov; 311(1):227-33. PubMed ID: 6151568
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence that (+)-bupranolol interacts directly with myocardial beta-adrenoceptors. Control of optical purity with differential thermal analysis.
    Wächter W; Münch U; Lemoine H; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):1-8. PubMed ID: 6259541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic method for the quantitative analysis of the aryloxypropanolamines propranolol, metoprolol and atenolol in plasma and tissue.
    Winkler H; Ried W; Lemmer B
    J Chromatogr; 1982 Mar; 228():223-34. PubMed ID: 7076746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal delivery of bupranolol: pharmacodynamics and beta-adrenoceptor occupancy.
    Wellstein A; Küppers H; Pitschner HF; Palm D
    Eur J Clin Pharmacol; 1986; 31(4):419-22. PubMed ID: 3028816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radioautographic study on the incorporation of 14C-bupranolol (beta-blocking agent) into the rabbit eye.
    Tsukahara S; Yoshida K; Nagata T
    Histochemistry; 1980; 68(3):237-44. PubMed ID: 7462003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validated HPLC method for quantitative determination of talinolol in rat plasma and application to a preclinical pharmacokinetic study.
    Pathak SM; Musmade PB; Bhat KM; Udupa N
    Bioanalysis; 2010 Jan; 2(1):95-104. PubMed ID: 21083123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of the beta-blocker 14C-bupranolol in humans, dogs, and rhesus monkeys.
    Waller AR; Chasseaud LF; Bonn R; Taylor T; Darragh A; Girkin R; Down WH; Doyle E
    Drug Metab Dispos; 1982; 10(1):51-4. PubMed ID: 6124383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of beta-blocking activity of low-dose bupranolol.
    Weisser B; Noack E; Düsing R; Glänzer K
    Int J Clin Pharmacol Res; 1989; 9(1):9-14. PubMed ID: 2565296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic studies on the penetration and distribution of bupranolol in the rabbit eye].
    Schmitz J; Dahnke HG; Zemitis A; Koglin K; Mosebach KO; Dardenne MU
    Fortschr Ophthalmol; 1982; 79(4):374-8. PubMed ID: 7185717
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of residues of carazolol and a number of tranquilizers in swine kidney by high-performance liquid chromatography with ultraviolet and fluorescence detection.
    Keukens HJ; Aerts MM
    J Chromatogr; 1989 Feb; 464(1):149-61. PubMed ID: 2715246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of tranquilisers and carazolol residues in animal tissue using high-performance liquid chromatography with electrochemical detection.
    Rose MD; Shearer G
    J Chromatogr; 1992 Oct; 624(1-2):471-7. PubMed ID: 1362965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of ophthalmic therapeutic metipranolol and its degradation product by reversed-phase high-performance liquid chromatography.
    Vidal E; Guigues M; Balansard G; Elias R
    J Chromatogr; 1985 Nov; 348(1):304-8. PubMed ID: 2868022
    [No Abstract]   [Full Text] [Related]  

  • 15. High-performance liquid chromatographic method for the determination of esmolol hydrochloride in solutions and parenteral formulations.
    Karnatz NN; Baaske DM; Herbranson DE; Eliason MS
    J Chromatogr; 1985 Aug; 330(2):420-4. PubMed ID: 4066833
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of citalopram in plasma and brain tissue of the rat by high-performance liquid chromatography with ultraviolet detection.
    Wang NS; Lemmer B
    J Chromatogr; 1989 Mar; 488(2):492-7. PubMed ID: 2745637
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toxicologic analysis of some adrenergic-beta blockers in the diagnosis of intoxications].
    Wachowiak R; Tezyk A
    Arch Med Sadowej Kryminol; 2003; 53(4):289-99. PubMed ID: 14971294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of mitiglinide in rat plasma by high-performance liquid chromatography with UV detection.
    Lushan Y; Su Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):204-7. PubMed ID: 16520101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple method for the measurement of pineal melatonin with a high performance liquid chromatography--UV detection.
    Yamada K; Sakamoto Y; Satoh T
    Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):283-7. PubMed ID: 6515119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of D-tubocurarine chloride or metocurine iodide in human plasma by high-performance liquid chromatography with ultraviolet detection.
    Avram MJ; Shanks CA
    J Chromatogr; 1984 Mar; 306():398-404. PubMed ID: 6715480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.